Seventy-one patients with localized or metastatic PDGFRA-mutant GIST were included: 37 (52.1%) with D842V-mutant GISTs (group A) and 34 (47.9%) with non–D842V-mutant GISTs (group B). Here, PDGFRA is linked to gastrointestinal stromal tumor.